- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06000163
Normal Reference Values in Han Adults of Skin Thickness and Blood Flow by High-frequency Ultrasound (NOVAS-HFUS)
Normal Reference Values in Han Adults of Skin Thickness and Blood Flow by High-frequency Ultrasound: a Multicenter Study in China
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The skin is the body's largest organ and acts as a protective, permeable barrier against pathogen invasion and against chemical and physical attacks. Long-term exposure to solar ultraviolet radiation is a major factor in exogenous skin aging. With the gradual improvement of living standards and the development of medical cosmetology technology, Chinese consumers have gradually increased their acceptance of cosmetology consumption. Facial skin, as one of the important indicators of "beauty", has obviously received the attention of cosmetic surgeons and dermatologists. Skin thickness is one of the important indicators of facial aging. However, different gender, different parts of the skin thickness is very different, especially the facial skin, the thickness of the epidermis, dermis is different, and the facial plastic surgery, injection treatment, photoelectric treatment has a close relationship. In addition, the dermis is rich in blood vessels, especially in its deep layers, which play an important role in the nutritional support of tissues and homeostasis of the internal environment. With the increase of age, the degree of dermal vascularization decreases, which is also one of the factors affecting skin aging. Therefore, in aesthetic medicine, more accurate quantitative evaluation of skin thickness and blood flow rather than simple subjective evaluation is very important.
Ultrasound is a non-invasive imaging technique widely used in clinic. In recent years, with the development of ultrasound technology, the frequency of ultrasonic probes has been increasing. Because of its higher resolution, high-frequency ultrasound can clearly display the layer and structure of the skin, and achieve accurate measurement of skin thickness and evaluation of dermal blood flow. High-frequency ultrasound has become a new non-invasive tool for the diagnosis of skin diseases, aesthetic medicine and preoperative and postoperative evaluation. The purpose of this multi-center Study is to establish the normal reference values of skin thickness and blood flow parameters by high-frequency ultrasound in Chinese Han adults, and to explore the influencing factors, so as to provide quantitative reference for the evaluation of facial skin aging degree and cosmetic treatment.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Chunyan Ma, PHD
- Phone Number: 13998816448
- Email: cmu1h_mcy@126.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Han nationality;
- Ages 18-79;
- Normal blood pressure (139-90/89-60mmHg);
- Body mass index < 30 kg/m2;
- Blood routine, fasting blood glucose, blood lipid, liver and kidney function, electrocardiogram were normal;
- No history of skin disease, connective tissue disease, cardiovascular disease, diabetes, severe liver and kidney dysfunction.
- No history of drug use affecting cardiovascular system.
Exclusion Criteria:
- People with skin diseases (such as eczema, psoriasis, scleroderma, etc.);
- Any skin disease at the test site (such as dermatitis, acne, breakages, previous skin lesions, etc.);
- chronic systemic diseases;
- Use corticosteroid drugs or immunosuppressants;
- Pregnant or lactating women;
- People who have been exposed to ultraviolet radiation for a long time or have a history of sun exposure within 3 months;
- The examined skin area has been previously treated with other methods;
- Unable to cooperate with the inspector.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dermal thickness
Time Frame: 1 day
|
Dermal thickness reflects the change in skin structure and can be used to assess skin aging.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood flow velocity of dermal artery
Time Frame: 1 day
|
Blood flow velocity of dermal artery reflects the hemodynamic changes of skin and can be used for early evaluation of skin aging.
|
1 day
|
Collaborators and Investigators
Investigators
- Principal Investigator: Lixin Jiang, PHD, Shanghai Jiao Tong University School of Medicine
- Principal Investigator: Xinhua Ye, PHD, The First Affiliated Hospital with Nanjing Medical University
- Principal Investigator: WeiDong Ren, PHD, Shengjing Hospital
- Principal Investigator: Xin Guan, PHD, Tianjin Chest Hospital
- Principal Investigator: Hongning Yin, PHD, The Second Hospital of Hebei Medical University
- Principal Investigator: Xiaoshan Zhang, PHD, The Affiliated Hospital of Inner Mongolia Medical University
- Principal Investigator: Yuhong Zhang, PHD, The Second Affiliated Hospital of Dalian Medical University
- Principal Investigator: Qingxiong Yue, PHD, Dalian Municipal Central Hospital
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NOVAS-HFUS-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteer
-
University Magna GraeciaNot yet recruitingHealthy Volunteer | Healthy Volunteer StudyItaly
-
AbbVieRecruiting
-
AbbVieNot yet recruiting
-
Advenchen Laboratories Nanjing Ltd.Not yet recruitingHealthy VolunteerChina
-
Hinge BioRecruiting
-
HK inno.N CorporationNot yet recruitingHealthy VolunteerSouth Korea
-
AbbVieRecruitingHealthy VolunteerUnited States
-
Mirador Therapeutics, Inc.Recruiting
-
AbbVieRecruitingHealthy VolunteerUnited States
-
Protagonist Therapeutics, Inc.RecruitingHealthy VolunteerAustralia
Clinical Trials on high-frequency ultrasound
-
First Hospital of China Medical UniversityNot yet recruitingHealthy Volunteer | Artery Disease
-
Weill Medical College of Cornell UniversityCompletedAge Related Macular DegenerationUnited States
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedMelanoma | Lymphoma | Lymphoma, Non-Hodgkin | Carcinoma, Basal CellCanada
-
Weill Medical College of Cornell UniversityRiverside Research InstituteUnknownGlaucoma | Age-Related Macular Degeneration | TumorsUnited States
-
Centre Hospitalier Universitaire de NiceCompletedChronic Inflammatory Demyelinating PolyradiculoneuropathyFrance
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceUnknownEhlers-Danlos Syndrome | Fibromuscular DysplasiaFrance
-
Wenzhou Medical UniversityActive, not recruitingZonule of Zinn Abnormality | Zonular CataractChina
-
Qilu Hospital of Shandong UniversityChinese PLA General Hospital; Xuanwu Hospital, Beijing; Shenzhen People's Hospital and other collaboratorsNot yet recruitingStroke | Coronary Disease | AtherosclerosisChina
-
Columbia UniversityNational Eye Institute (NEI)Completed
-
University of PisaRecruiting